Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

16. Februar 2017 01:30 ET | Quelle: Weifa ASA

Weifa ASA: Record-breaking fourth quarter and full year 2016, dividend proposed

Oslo, 16 February 2017 Record quarterly revenues of NOK 114.5 million, up 17% Driven by Asan and organic growth Fourth quarter adjusted EBITDA of NOK 28.8 million (margin 25.2%) ...
10. Februar 2017 04:00 ET | Quelle: Weifa ASA

Weifa ASA: Invitation to presentation of Weifa's Q4 2016 results, Thursday 16 February

Oslo, 10 February 2017 Weifa ASA (OSE: WEIFA), Norway's leading consumer health company, will release its fourth quarter and full-year 2016 results on Thursday 16 February 2017. The results will...
12. Januar 2017 04:15 ET | Quelle: Weifa ASA

Weifa ASA: New license agreement with AFT Pharmaceuticals for Nordic rights to groundbreaking product line within Pain Management

Weifa has in-licensed a patented fixed-combination product line within pain management from AFT Pharmaceuticals ("AFT") in New Zealand. The agreement gives rights to commercialize the products in...
14. Dezember 2016 10:01 ET | Quelle: Weifa ASA

Weifa ASA: Launch of the Asan brand in Finland through a cooperation agreement with Midsona Finland Oy.

Weifa has signed a 3-year cooperation agreement with Midsona Finland Oy(Finland). The agreement covers Weifa's range of Asan products. Midsona will distribute and sell the products on an exclusive...

Vorherige Seite